SOTERA HEALTH COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.4 USD | +0.71% |
|
+4.11% | -32.34% |
| 04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| 04-03 | Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18 | MT |
| Sales 2024 * | 1.1B 1.5B | Sales 2025 * | 1.18B 1.61B | Capitalization | 3.23B 4.4B |
|---|---|---|---|---|---|
| Net income 2024 * | 97M 132M | Net income 2025 * | 149M 203M | EV / Sales 2024 * | 4.69 x |
| Net Debt 2024 * | 1.93B 2.64B | Net Debt 2025 * | 1.79B 2.44B | EV / Sales 2025 * | 4.26 x |
| P/E ratio 2024 * |
33.3
x | P/E ratio 2025 * |
22
x | Employees | 3,000 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.78% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sotera Health Company
More recommendations
More press releases
| 1 day | +0.71% | ||
| 1 week | +4.11% | ||
| Current month | -5.08% | ||
| 1 month | -5.08% | ||
| 3 months | -23.90% | ||
| 6 months | -8.87% | ||
| Current year | -32.34% |
1 week
11.01
11.65
1 month
10.7112.03
Current year
10.7117.44
1 year
10.7119.40
3 years
5.7827.38
5 years
5.7830.38
10 years
5.7830.38
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Petras
CEO | Chief Executive Officer | 56 | 16-05-31 |
Jon Lyons
DFI | Director of Finance/CFO | - | 23-06-25 |
Robert Hauzie
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Vincent Petrella
BRD | Director/Board Member | 63 | 20-10-31 |
Dave Donnini
BRD | Director/Board Member | 58 | 20-09-30 |
Dean Mihas
BRD | Director/Board Member | 57 | 20-09-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 9 M€ | -.--% | - | |
| 0.02% | 33 M€ | +0.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 11.4 | +0.71% | 737,652 |
| 24-04-25 | 11.32 | +0.44% | 721,160 |
| 24-04-24 | 11.27 | -0.97% | 1,168,146 |
| 24-04-23 | 11.38 | +2.61% | 1,142,912 |
| 24-04-22 | 11.09 | +1.28% | 716,627 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotes
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Companyâs segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
Calendar
2024-05-02
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
11.4
USD
Average target price
16.75
USD
Spread / Average Target
+46.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -32.34% | 3.23B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.59B | |
| -12.71% | 16.73B | |
| -2.07% | 16.36B | |
| -2.63% | 14.92B | |
| -31.58% | 11.77B | |
| +0.34% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- SHC Stock
